# 3 Month PHI PAD PoM Study

> **NCT02135848** · PHASE2 · COMPLETED · sponsor: **GlaxoSmithKline** · enrollment: 46 (actual)

## Conditions studied

- Vascular Disease, Peripheral

## Interventions

- **DRUG:** GSK1278863
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT02135848
- **Lead sponsor:** GlaxoSmithKline
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-10-15
- **Primary completion:** 2011-11-01
- **Final completion:** 2011-11-01
- **Target enrollment:** 46 (ACTUAL)
- **Last updated:** 2017-10-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02135848

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02135848, "3 Month PHI PAD PoM Study". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT02135848. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*